GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of EUR 63.85 billion. The enterprise value is 77.97 billion.

Market Cap	63.85B
Enterprise Value	77.97B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Feb 20, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.75%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.92B

Valuation Ratios

The trailing PE ratio is 20.50.

PE Ratio	20.50
Forward PE	n/a
PS Ratio	1.68
PB Ratio	4.03
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.82, with an EV/FCF ratio of 12.51.

EV / Earnings	25.04
EV / Sales	2.12
EV / EBITDA	7.82
EV / EBIT	10.79
EV / FCF	12.51

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.

Current Ratio	0.78
Quick Ratio	0.50
Debt / Equity	1.30
Debt / EBITDA	1.99
Debt / FCF	3.30
Interest Coverage	10.06

Financial Efficiency

Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 12.70%.

Return on Equity (ROE)	22.80%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	12.70%
Return on Capital Employed (ROCE)	16.37%
Revenue Per Employee	552,841
Profits Per Employee	45,371
Employee Count	68,629
Asset Turnover	0.53
Inventory Turnover	1.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.32% in the last 52 weeks. The beta is 0.30, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-17.32%
50-Day Moving Average	17.48
200-Day Moving Average	17.52
Relative Strength Index (RSI)	39.25
Average Volume (20 Days)	906,148

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of EUR 37.94 billion and earned 3.11 billion in profits. Earnings per share was 0.75.

Revenue	37.94B
Gross Profit	27.25B
Operating Income	7.48B
Pretax Income	4.20B
Net Income	3.11B
EBITDA	10.05B
EBIT	7.48B
Earnings Per Share (EPS)	0.75

Full Income Statement

Balance Sheet

The company has 5.23 billion in cash and 20.54 billion in debt, giving a net cash position of -15.31 billion.

Cash & Cash Equivalents	5.23B
Total Debt	20.54B
Net Cash	-15.31B
Net Cash Per Share	n/a
Equity (Book Value)	15.82B
Book Value Per Share	4.05
Working Capital	-5.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.93 billion and capital expenditures -1.69 billion, giving a free cash flow of 6.23 billion.

Operating Cash Flow	7.93B
Capital Expenditures	-1.69B
Free Cash Flow	6.23B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.81%, with operating and profit margins of 19.71% and 8.21%.

Gross Margin	71.81%
Operating Margin	19.71%
Pretax Margin	11.08%
Profit Margin	8.21%
EBITDA Margin	26.49%
EBIT Margin	19.71%
FCF Margin	16.43%

Dividends & Yields

This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 4.68%.

Dividend Per Share	0.72
Dividend Yield	4.68%
Dividend Growth (YoY)	7.59%
Years of Dividend Growth	1
Payout Ratio	94.91%
Buyback Yield	-0.75%
Shareholder Yield	3.93%
Earnings Yield	4.88%
FCF Yield	9.76%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.81
Piotroski F-Score	n/a